Why Are Fulcrum Therapeutics Shares Trading Higher Today?
Fulcrum Therapeutics Inc (NASDAQ: FULC) is trading higher again Wednesday after the stock saw positive analyst coverage following the company's better-than-expected financial results and announcement that its Phase 1 study of FTX-6058 for sickle cell disease showed proof of mechanism and
